Medexus Pharmaceuticals Inc. provided revenue guidance for the fourth quarter and full year ended March 31, 2023. The company expects to deliver total revenue between $107 million and $108 million for fiscal year 2023, representing record annual revenue for the company and a year-over-year increase of at least 39.5%.

As part of this record annual revenue, the company expects to deliver total revenue between $28 million and $28.5 million for fiscal fourth quarter 2023, representing a year-over-year increase of at least 38.1%.